(Allergan plc)

	AGN latest price $190.0366 (-0.83%) ($188.9174 - $192.7209) on Thu. Oct. 4, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	0.99% (three month average)
RSI	57
Latest Price	$190.0366(-0.83%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.1% a day on average for past five trading days.
Weekly Trend	AGN advances 1.2% a week on average for past two weeks.
Market Behavior	Growth stock sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XBI(48%)    XLV(48%)    ARKG(47%)    IVW(46%)
Factors Impacting AGN price	AGN will decline at least -0.495% in a week (0% probabilities).   VIXM(-28%)    TLT(-23%)    UUP(-19%)    VXX(-15%)    IFRA(-14%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.495% (StdDev 0.99%)
Hourly BBV	0 ()
Intraday Trend	-1.1%

5 Day Moving Average	$190.48(-0.23%)
10 Day Moving Average	$189.21(0.44%)
20 Day Moving Average	$188.11(1.02%)
To recent high	-0.8%
To recent low	12.1%
Market Cap	$62.655b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed